CLINICAL_TRIALS
other
· 2026-02-23
Clinical Trial Update: R21/Matrix-M in African Children Against Clinical Malaria [Phase 3]
Summary
Phase 3 clinical trial of the malaria vaccine R21/Matrix-M in African children is active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oxford | Conditions: Malaria | Phase 3 | Status: ACTIVE_NOT_RECRUITING